Literature DB >> 22037334

Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines.

Martha Polovich1, Susan Martin.   

Abstract

PURPOSE/
OBJECTIVES: To determine patterns of personal protective equipment (PPE) used by oncology nurses while handling hazardous drugs (HDs) and to assess knowledge of the 2004 National Institute for Occupational Safety and Health (NIOSH) Alert and its effect on precaution use.
DESIGN: Descriptive, correlational.
SETTING: The Oncology Nursing Society 31st Annual Congress in Boston, MA, in 2006. SAMPLE: 330 nurses who prepared and/or administered chemotherapy.
METHODS: Nurses described HD safe-handling precaution use by self-report survey. MAIN RESEARCH VARIABLES: The availability and use of biologic safety cabinets and PPE.
FINDINGS: Respondents were well educated (57% had a bachelor's degree or more), experienced (X = 19, SD = 10.2 years in nursing and X = 12, SD = 7.9 years in oncology), and certified (70%; majority OCN®). Forty-seven percent of respondents were aware of the NIOSH Alert. Thirty-five percent of all participants and 93% of nurses in private practice settings reported preparing chemotherapy. Glove use (95%-100%) was higher than that reported in earlier studies, and gown use for drug preparation (65%), drug administration (50%), and handling excretions (23%) have remained unchanged. Double-gloving was rare (11%-18%). Nurses in private practices were less likely to have chemotherapy-designated PPE available, use PPE, and use spill kits for HD spills.
CONCLUSIONS: Nurses have adopted glove use for HD handling; however, gown use remains comparatively low. Chemotherapy-designated PPE is not always provided by employers. Nurses lack awareness of current safety guidelines. IMPLICATIONS FOR NURSING: Nurses must know about the risks of HD exposure and ways to reduce exposure. Employers must provide appropriate PPE and encourage its use. Alternative methods of disseminating safety recommendations are needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037334     DOI: 10.1188/11.ONF.718-726

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

Review 1.  Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.

Authors:  Thomas H Connor; Christina C Lawson; Martha Polovich; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2014-09       Impact factor: 2.162

2.  Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs.

Authors:  James M Boiano; Andrea L Steege; Marie H Sweeney
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

3.  Factors Influencing Nurses' Use of Hazardous Drug Safe-Handling Precautions.

Authors:  Amy Callahan; Nancy J Ames; Mary Lou Manning; Kate Touchton-Leonard; Li Yang; Gwenyth Wallen
Journal:  Oncol Nurs Forum       Date:  2016-05-01       Impact factor: 2.172

4.  Lessons Learned From a Practice-Based, Multisite Intervention Study With Nurse Participants.

Authors:  Christopher R Friese; Kari Mendelsohn-Victor; Pamela Ginex; Carol M McMahon; Alex J Fauer; Marjorie C McCullagh
Journal:  J Nurs Scholarsh       Date:  2017-01-18       Impact factor: 3.176

5.  Hazardous Drug Exposure: Case Report Analysis From a Prospective, Multisite Study of Oncology Nurses' Exposure in Ambulatory Settings.

Authors:  Christopher R Friese; Mandy Wong; Alex Fauer; Kari Mendelsohn-Victor; Martha Polovich; Marjorie C McCullagh
Journal:  Clin J Oncol Nurs       Date:  2020-06-01       Impact factor: 1.027

6.  Antineoplastic drug exposure in an ambulatory setting: a pilot study.

Authors:  Christopher R Friese; Cristin McArdle; Ting Zhao; Duxin Sun; Ivan Spasojevic; Martha Polovich; Marjorie C McCullagh
Journal:  Cancer Nurs       Date:  2015 Mar-Apr       Impact factor: 2.592

7.  DEFENS - Drug Exposure Feedback and Education for Nurses' Safety: study protocol for a randomized controlled trial.

Authors:  Christopher R Friese; Kari Mendelsohn-Victor; Bo Wen; Duxin Sun; Kathleen Sutcliffe; James J Yang; David L Ronis; Marjorie C McCullagh
Journal:  Trials       Date:  2015-04-17       Impact factor: 2.279

8.  Risks to health professionals from hazardous drugs in Iran: a pilot study of understanding of healthcare team to occupational exposure to cytotoxics.

Authors:  Abdol Ali Shahrasbi; Minoo Afshar; Farnaz Shokraneh; Faezeh Monji; Mahjabin Noroozi; Maryam Ebrahimi-Khojin; Seyed Farzam Madani; Mehdi Ahadi-Barzoki; Mehdi Rajabi
Journal:  EXCLI J       Date:  2014-05-09       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.